10-Q Filing

Company

Travere Therapeutics, Inc.

Filed

March 6, 2013

Period of Report

November 30, 2012

Accession Number

0001193805-13-000588

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →